Abstract
Perioral dermatitis is a common acneiform facial eruption found in both adults and children. Its variants are periorificial and granulomatous periorificial dermatitis. The etiology of perioral dermatitis remains unknown; however, topical corticosteroid use on the face commonly precedes the manifestation of this condition. There are an overwhelming number of treatment options for perioral dermatitis, and the options in children are slightly different from those in adults for both systemic medications and topical treatment. This article provides a literature review of the various applicable treatments available based on the level and quality of the evidence by the US Preventive Service Task Force. Oral tetracycline reveals the best valid evidence. However, if the patient is less than 8 years old, then this oral therapy may not be suitable. Topical metronidazole, erythromycin, and pimecrolimus also represent effective treatment choices with good evidence. Topical corticosteroid use is common in these cases and the question of whether it is a good treatment or a cause remains unanswered. Corticosteroid cream can improve the clinical picture, but there is a risk of rebound when treatment is stopped. We propose a treatment algorithm to assist dermatologists, pediatric dermatologists, and general practitioners encountering this condition.
Similar content being viewed by others
References
Nguyen V, Eichenfield LF. Periorificial dermatitis in children and adolescents. J Am Acad Dermatol. 2006;55(5):781–5.
Hafeez ZH. Perioral dermatitis: an update. Int J Dermatol. 2003;42(7):514–7.
Laude TA, Salvemini JN. Perioral dermatitis in children. Semin Cutan Med Surg. 1999;18(3):206–9.
Lipozencic J, Ljubojevic S. Perioral dermatitis. Clin Dermatol. 2011;29(2):157–61.
Hengge UR, Ruzicka T, Schwartz RA, Cork MJ. Adverse effects of topical glucocorticosteroids. J Am Acad Dermatol. 2006;54(1):1–15 quiz 6-8.
Bradford LG, Montes LF. Perioral dermatitis and Candida albicans. Arch Dermatol. 1972;105(6):892–5.
Takiwaki H, Tsuda H, Arase S, Takeichi H. Differences between intrafollicular microorganism profiles in perioral and seborrhoeic dermatitis. Clin Exp Dermatol. 2003;28(5):531–4.
Hsu CK, Hsu MM, Lee JY. Demodicosis: a clinicopathological study. J Am Acad Dermatol. 2009;60(3):453–62.
Berardi P, Benvenuti S, Genga A, Cecchini F. Demonstration of fusobacteria in eruptions of perioral dermatitis using the tape stripping toluidine blue (TSTB) method. J Eur Acad Dermatol Venereol. 1994;3:495–9.
Wells K, Brodell RT. Topical corticosteroid ‘addiction’. A cause of perioral dermatitis. Postgrad Med. 1993;93(5):225–30.
Shiri J, Amichai B. Perioral dermatitis induced by inhaled corticosteroids. J Dermatol Treat. 1998;9:259–60.
Dubus JC, Marguet C, Deschildre A, Mely L, Le Roux P, Brouard J, et al. Local side-effects of inhaled corticosteroids in asthmatic children: influence of drug, dose, age, and device. Allergy. 2001;56(10):944–8.
Kumar P, Parashette KR, Noronha P. Letter: Perioral dermatitis in a child associated with an inhalation steroid. Dermatol Online J. 2010;16(4):13.
Clementson B, Smidt AC. Periorificial dermatitis due to systemic corticosteroids in children: report of two cases. Pediatr Dermatol. 2012;29(3):331–2.
Mellette JR, Aeling JL, Nuss DD. Letter: Fluoride tooth paste: a cause of perioral dermatitis. Arch Dermatol. 1976;112(5):730–1.
Ferlito TA. Tartar-control toothpaste and perioral dermatitis. J Clin Orthod. 1992;26(1):43–4.
Abele DC. ‘Moisturizers’ and perioral dermatitis. Arch Dermatol. 1977;113(1):110.
Malik R, Quirk CJ. Topical applications and perioral dermatitis. Australas J Dermatol. 2000;41(1):34–8.
Abeck D, Geisenfelder B, Brandt O. Physical sunscreens with high sun protection factor may cause perioral dermatitis in children. J Dtsch Dermatol Ges. 2009;7(8):701–3.
Guarneri F, Marini H. An unusual case of perioral dermatitis: possible pathogenic role of neurogenic inflammation. J Eur Acad Dermatol Venereol. 2007;21(3):410–2.
Rallis G, Papakosta V, Petrakogiannis C, Zachariades N. Perioral dermatitis following orthognathic surgery. Plast Reconstr Surg. 2004;113(2):771–3.
Satyawan I, Oranje AP, van Joost T. Perioral dermatitis in a child due to rosin in chewing gum. Contact Dermat. 1990;22(3):182–3.
Jansen T. Perioral dermatitis successfully treated with topical adapalene. J Eur Acad Dermatol Venereol. 2002;16(2):175–7.
Dirschka T, Szliska C, Jackowski J, Tronnier H. Impaired skin barrier and atopic diathesis in perioral dermatitis. J Dtsch Dermatol Ges. 2003;1(3):199–203.
Adams SJ, Davison AM, Cunliffe WJ, Giles GR. Perioral dermatitis in renal transplant recipients maintained on corticosteroids and immunosuppressive therapy. Br J Dermatol. 1982;106(5):589–92.
Hogan DJ. Perioral dermatitis. Curr Probl Dermatol. 1995;22:98–104.
Rodriguez-Martin M, Saez-Rodriguez M, Carnerero-Rodriguez A, Rodriguez-Garcia F, Cabrera de Paz R, Sidro-Sarto M, et al. Treatment of perioral dermatitis with topical pimecrolimus. J Am Acad Dermatol. 2007;56(3):529–30.
Goss JM, Nord KM, Olarte MR, Grossman ME. Perioral dermatitis in a patient with myasthenia gravis following systemic corticosteroid treatment. Br J Dermatol. 2007;156(3):582.
Kuflik JH, Janniger CK, Piela Z. Perioral dermatitis: an acneiform eruption. Cutis. 2001;67(1):21–2.
Urbatsch AJ, Frieden I, Williams ML, Elewski BE, Mancini AJ, Paller AS. Extrafacial and generalized granulomatous periorificial dermatitis. Arch Dermatol. 2002;138(10):1354–8.
Hansen KK, McTigue MK, Esterly NB. Multiple facial, neck, and upper trunk papules in a black child. Childhood granulomatous perioral dermatitis with involvement of the neck and upper trunk. Arch Dermatol. 1992;128(10):1396–7, 9.
Frieden IJ, Prose NS, Fletcher V, Turner ML. Granulomatous perioral dermatitis in children. Arch Dermatol. 1989;125(3):369–73.
Marks R, Black MM. Perioral dermatitis. A histopathologic study of 26 cases. Br J Dermatol. 1971;84(3):242–7.
Misago N, Nakafusa J, Narisawa Y. Childhood granulomatous periorificial dermatitis: lupus miliaris disseminatus faciei in children? J Eur Acad Dermatol Venereol. 2005;19(4):470–3.
van de Scheur MR, van der Waal RI, Starink TM. Lupus miliaris disseminatus faciei: a distinctive rosacea-like syndrome and not a granulomatous form of rosacea. Dermatology. 2003;206(2):120–3.
Moloney FJ, Egan CA. Case 3. Acne agminata (lupus miliaris disseminatus faciei). Clin Exp Dermatol. 2003;28(6):685–6.
Crawford GH, Pelle MT, James WD. Rosacea: I. Etiology, pathogenesis, and subtype classification. J Am Acad Dermatol. 2004;51(3):327–41 quiz 42-4.
Drolet B, Paller AS. Childhood rosacea. Pediatr Dermatol. 1992;9(1):22–6.
Smith KW. Perioral dermatitis with histopathologic features of granulomatous rosacea: successful treatment with isotretinoin. Cutis. 1990;46(5):413–5.
Khokhar O, Khachemoune A. A case of granulomatous rosacea: sorting granulomatous rosacea from other granulomatous diseases that affect the face. Dermatol Online J. 2004;10(1):6.
Kroshinsky D, Glick SA. Pediatric rosacea. Dermatol Ther. 2006;19(4):196–201.
Tarm K, Creel NB, Krivda SJ, Turiansky GW. Granulomatous periorificial dermatitis. Cutis. 2004;73(6):399–402.
Williams HC, Ashworth J, Pembroke AC, Breathnach SM. FACE—facial Afro-Caribbean childhood eruption. Clin Exp Dermatol. 1990;15(3):163–6.
Knautz MA, Lesher JL Jr. Childhood granulomatous periorificial dermatitis. Pediatr Dermatol. 1996;13(2):131–4.
Nedorost ST. Medical Pearl: the evaluation of perioral dermatitis: use of an extended patch test series. J Am Acad Dermatol. 2007;56(5 Suppl):S100–2.
Wilkinson DS, Kirton V, Wilkinson JD. Perioral dermatitis: a 12-year review. Br J Dermatol. 1979;101(3):245–57.
Dirschka T, Weber K, Tronnier H. Topical cosmetics and perioral dermatitis. J Dtsch Dermatol Ges. 2004;2(3):194–9.
Frumess GM, Lewis HM. Light-sensitive seborrheid. AMA Arch Derm. 1957;75(2):245–8.
Miller WS. Tetracycline in the treatment of perioral dermatitis. N C Med J. 1971;32(11):471–2.
Macdonald A, Feiwel M. Perioral dermatitis: aetiology and treatment with tetracycline. Br J Dermatol. 1972;87(4):315–9.
Sneddon I. Perioral dermatitis. Br J Dermatol. 1972;87(5):430–4.
Sneddon I. A trial of hydrocortisone butyrate in the treatment of rosacea and perioral dermatitis. Br J Dermatol. 1973;89(5):505–8.
Bendl BJ. Perioral dermatitis: etiology and treatment. Cutis. 1976;17(5):903–8.
Urabe H, Koda H. Perioral dermatitis and rosacea-like dermatitis: clinical features and treatment. Dermatologica. 1976;152(Suppl 1):155–60.
Cochran RE, Thomson J. Perioral dermatitis: a reappraisal. Clin Exp Dermatol. 1979;4(1):75–80.
Cotterill JA. Perioral dermatitis. Br J Dermatol. 1979;101(3):259–62.
Wilson RG. Topical tetracycline in the treatment of perioral dermatitis. Arch Dermatol. 1979;115(5):637.
Bikowski JB. Topical therapy for perioral dermatitis. Cutis. 1983;31(6):678–82.
Coskey RJ. Perioral dermatitis. Cutis. 1984;34(1):55–6, 8.
Veien NK, Munkvad JM, Nielsen AO, Niordson AM, Stahl D, Thormann J. Topical metronidazole in the treatment of perioral dermatitis. J Am Acad Dermatol. 1991;24(2 Pt 1):258–60.
Manders SM, Lucky AW. Perioral dermatitis in childhood. J Am Acad Dermatol. 1992;27(5 Pt 1):688–92.
Weber K, Thurmayr R. A topical erythromycin preparation and oral tetracycline for the treatment of perioral dermatitis: a placebo-controlled trial. J Dermatol Treat. 1993;4:57–9.
Boeck K, Abeck D, Werfel S, Ring J. Perioral dermatitis in children—clinical presentation, pathogenesis-related factors and response to topical metronidazole. Dermatology. 1997;195(3):235–8.
Weber K. How I treat perioral dermatitis: non-compliance with the treatment guidelines. Dermatology. 2003;207(2):215.
Jansen T. Azelaic acid as a new treatment for perioral dermatitis: results from an open study. Br J Dermatol. 2004;151(4):933–4.
Richey DF, Hopson B. Photodynamic therapy for perioral dermatitis. J Drugs Dermatol. 2006;5(2 Suppl):12–6.
Oppel T, Pavicic T, Kamann S, Brautigam M, Wollenberg A. Pimecrolimus cream (1%) efficacy in perioral dermatitis—results of a randomized, double-blind, vehicle-controlled study in 40 patients. J Eur Acad Dermatol Venereol. 2007;21(9):1175–80.
Schwarz T, Kreiselmaier I, Bieber T, Thaci D, Simon JC, Meurer M, et al. A randomized, double-blind, vehicle-controlled study of 1% pimecrolimus cream in adult patients with perioral dermatitis. J Am Acad Dermatol. 2008;59(1):34–40.
Kihiczak GG, Cruz MA, Schwartz RA. Periorificial dermatitis in children: an update and description of a child with striking features. Int J Dermatol. 2009;48(3):304–6.
Jansen T, Melnik BC, Schadendorf D. Steroid-induced periorificial dermatitis in children—clinical features and response to azelaic acid. Pediatr Dermatol. 2010;27(2):137–42.
Ishiguro N, Maeda A, Suzuki K, Yamana Y, Fukuya Y, Kawashima M. Three cases of perioral dermatitis related to fusobacteria treated with beta-lactam antibiotics. J Dermatolog Treat. 2014;25(6):507–9.
Miller SR, Shalita AR. Topical metronidazole gel (0.75%) for the treatment of perioral dermatitis in children. J Am Acad Dermatol. 1994;31(5 Pt 2):847–8.
Zalaudek I, Di Stefani A, Ferrara G, Argenziano G. Childhood granulomatous periorificial dermatitis: a controversial disease. J Dtsch Dermatol Ges. 2005;3(4):252–5.
Choi YL, Lee KJ, Cho HJ, Kim WS, Lee JH, Yang JM, et al. Case of childhood granulomatous periorificial dermatitis in a Korean boy treated by oral erythromycin. J Dermatol. 2006;33(11):806–8.
Hussain W, Daly BM. Granulomatous periorificial dermatitis in an 11-year-old boy: dramatic response to tacrolimus. J Eur Acad Dermatol Venereol. 2007;21(1):137–9.
Ahmed I. Clinicopathologic challenge. Childhood granulomatous peri-orificial dermatitis with extra-facial lesions. Int J Dermatol. 2007;46(2):143–5.
Rodriguez-Caruncho C, Bielsa I, Fernandez-Figueras MT, Ferrandiz C. Childhood granulomatous periorificial dermatitis with a good response to oral metronidazole. Pediatr Dermatol. 2013;30(5):e98–9.
Ellis CN, Stawiski MA. The treatment of perioral dermatitis, acne rosacea, and seborrheic dermatitis. Med Clin North Am. 1982;66(4):819–30.
Bikowski JB. Treatment of rosacea with doxycycline monohydrate. Cutis. 2000;66(2):149–52.
Bornhovd EC, Burgdorf WH, Wollenberg A. Immunomodulatory macrolactams for topical treatment of inflammatory skin diseases. Curr Opin Investig Drugs. 2002;3(5):708–12.
Schuller E, Oppel T, Bornhovd E, Wetzel S, Wollenberg A. Tacrolimus ointment causes inflammatory dendritic epidermal cell depletion but no Langerhans cell apoptosis in patients with atopic dermatitis. J Allergy Clin Immunol. 2004;114(1):137–43.
Hoetzenecker W, Ecker R, Kopp T, Stuetz A, Stingl G, Elbe-Burger A. Pimecrolimus leads to an apoptosis-induced depletion of T cells but not Langerhans cells in patients with atopic dermatitis. J Allergy Clin Immunol. 2005;115(6):1276–83.
Akamatsu H, Komura J, Asada Y, Miyachi Y, Niwa Y. Inhibitory effect of azelaic acid on neutrophil functions: a possible cause for its efficacy in treating pathogenetically unrelated diseases. Arch Dermatol Res. 1991;283(3):162–6.
Tarimci N, Sener S, Kilinc T. Topical sodium sulfacetamide/sulfur lotion. J Clin Pharm Ther. 1997;22(4):301.
Sauder D, Miller R, Gratton D. The treatment of rosacea: the safety and efficacy of sodium sulfacetamide 10% and sulfur 5% lotion is demonstrated in a double blind study. J Dermatolog Treat. 1997;8:79–85.
Nally JB, Berson DS. Topical therapies for rosacea. J Drugs Dermatol. 2006;5(1):23–6.
Olansky S. Old drug—in a new system—revisited. Cutis. 1977;19(6):852–4.
Mackley CL, Thiboutot DM. Diagnosing and managing the patient with rosacea. Cutis. 2005;75(4 Suppl):25–9.
Statement of Funding
None.
Conflict of Interest Disclosures
Dr. Tor A. Shwayder: None.
Dr. Therdpong Tempark: None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tempark, T., Shwayder, T.A. Perioral Dermatitis: A Review of the Condition with Special Attention to Treatment Options. Am J Clin Dermatol 15, 101–113 (2014). https://doi.org/10.1007/s40257-014-0067-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40257-014-0067-7